U.S. Luxury Stock News

NYSE:AIR
NYSE:AIRAerospace & Defense

Has AAR (AIR) Risen Too Far After Recent Aerospace And Defense Sector Interest

If you are wondering whether AAR at US$118.71 is still reasonably priced after a strong run, this article walks through what the current share price might imply about value. The stock has recent returns of 12.3% over 7 days, 4.1% over 30 days, 40.6% year to date and 101.0% over the last year, which naturally raises questions about how much upside or risk is now priced in. Recent headlines have focused on AAR's role within the broader Aerospace & Defense sector and how investors are reacting...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ASCENIV Pediatric Approval Tests ADMA Biologics Growth Story And Risks

FDA approves an expanded label for ASCENIV to include pediatric immunodeficiency patients aged two and older. The decision allows earlier intervention for immune compromised children and broadens ASCENIV’s eligible patient pool. The approval fulfills a key post marketing commitment for ADMA Biologics and may influence future commercial uptake. For ADMA Biologics (NasdaqGM:ADMA), this regulatory milestone arrives with the stock trading at $10.08 after a very large 5 year return and a 182.4%...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) Margin Reset From 21.3% To 10.3% Tests Bullish Growth Narratives

Onto Innovation (ONTO) has opened 2026 with Q1 revenue of US$291.9 million and basic EPS of US$0.68, setting a clear benchmark for how the rest of the year may shape up. The company has seen quarterly revenue move between US$218.2 million and US$291.9 million over the last six reported periods, while basic EPS has ranged from US$0.21 to US$1.30. This gives investors a concrete sense of how top line and per share earnings have tracked through recent cycles. With trailing 12 month net profit...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Perrigo (PRGO) Q1 Loss Of US$389.9 Million Tests Profit-Recovery Narratives

Perrigo (PRGO) opened Q1 2026 with revenue of US$969.2 million and a basic EPS loss of US$2.81, while net income excluding extra items came in at a loss of US$389.9 million. Over the past six reported quarters, revenue has ranged between US$969.2 million and US$1.14 billion and basic EPS has moved from a small profit of US$0.09 in Q3 2025 to a loss of US$10.20 in Q4 2025 and US$2.81 in the latest quarter, giving investors a wide view of how the income statement has changed across different...
NYSE:TTC
NYSE:TTCMachinery

Strong Q1 Beat And Guidance Hike Could Be A Game Changer For Toro (TTC)

The Toro Company recently reported past first-quarter fiscal 2026 results that exceeded analyst expectations and raised its full-year guidance, powered by strong professional segment performance and contributions from its Tornado Infrastructure Equipment acquisition. The company also underscored continued investment in innovation and operational excellence, suggesting its professional equipment and infrastructure offerings are becoming increasingly important within its overall business...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

Dentsply Sirona (XRAY) Narrower Q1 Loss Tests Bullish Margin Recovery Narrative

DENTSPLY SIRONA (XRAY) has opened 2026 with Q1 revenue of US$880 million and a basic EPS loss of US$0.05, alongside net income excluding extra items of a US$10 million loss, setting a cautious tone around current profitability. Over the past year, the company has seen quarterly revenue move between US$879 million and US$961 million, while basic EPS has ranged from a profit of US$0.10 to a loss of US$2.16. This underlines how volatile earnings have been even as the top line has stayed close to...
NYSE:NGVT
NYSE:NGVTChemicals

Assessing Ingevity (NGVT) Valuation After Strong Q1 2026 Earnings And Share Price Momentum

Ingevity (NGVT) has drawn fresh attention after reporting first quarter 2026 results, with sales of US$258 million and net income of US$59.8 million, compared to US$247.9 million and US$20.5 million a year earlier. See our latest analysis for Ingevity. The earnings release appears to have been a key catalyst for the recent share price move, with a 10.49% 1 month share price return and a 29.59% year to date share price return. The 1 year total shareholder return of 98.5% points to strong...
NYSE:OWL
NYSE:OWLCapital Markets

Has Blue Owl Capital (OWL) Rallied Too Far After Its Recent Share Price Surge

Wondering whether Blue Owl Capital is attractively priced today, or if the recent excitement has already been baked into the stock. The share price closed at US$10.54, with recent returns of 18.7% over 7 days and 24.7% over 30 days, set against a year to date return of negative 31.2% and a 1 year return of negative 38.3%. These swings sit against a backdrop of ongoing interest in alternative asset managers and the broader capital markets sector. In this environment, investors often reassess...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Is It Too Late To Consider Advanced Energy Industries (AEIS) After A 229% One Year Surge?

Investors may be wondering if Advanced Energy Industries at around US$360.81 is priced for perfection or still offers value, especially after such a strong run. The stock has been relatively steady over the last 7 days with a 0.2% decline. The 30 day return of 8.7% and 1 year return of 229.3% sit alongside multi year returns of 324.7% over 3 years and 315.6% over 5 years. Recent coverage has focused on Advanced Energy Industries as investors look at how its power conversion and control...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex Group (MRX) Earnings Growth And 10.2% Margin Keep Automation Narrative In Question

Marex Group (MRX) has opened 2026 with Q1 revenue of US$1.1b and basic EPS of US$1.57, alongside trailing twelve month EPS of US$4.65 and net income of US$333.9m, putting fresh numbers in front of investors watching its recent earnings momentum. Over the past year, the company has seen revenue move from US$2.36b to US$3.27b and EPS lift from US$2.96 to US$4.65 on a trailing basis, setting a clear context for how the latest quarterly print fits into the broader trend. Taken together with the...